Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
372.20
-4.60 (-1.22%)
May 27, 2026, 3:29 PM IST
NSE:ADVENZYMES Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,159 | 942.25 | 1,138 | 964.2 | 2,674 |
Short-Term Investments | 5,838 | 177.98 | 295.2 | 263.37 | 16.33 |
Trading Asset Securities | - | 4,803 | 4,029 | 3,596 | 1,019 |
Cash & Short-Term Investments | 6,998 | 5,923 | 5,461 | 4,823 | 3,709 |
Cash Growth | 18.15% | 8.45% | 13.23% | 30.03% | 16.38% |
Accounts Receivable | 1,450 | 1,154 | 985.68 | 1,003 | 884.91 |
Other Receivables | - | 7.09 | 15.9 | 20.06 | 63.54 |
Receivables | 1,453 | 1,162 | 1,003 | 1,025 | 949.31 |
Inventory | 1,773 | 1,573 | 1,485 | 1,240 | 1,209 |
Prepaid Expenses | - | 36.24 | 39.63 | 23.23 | 20.97 |
Other Current Assets | 212.73 | 104.48 | 109.44 | 110.27 | 155.55 |
Total Current Assets | 10,436 | 8,799 | 8,097 | 7,221 | 6,044 |
Property, Plant & Equipment | 3,270 | 3,146 | 3,073 | 2,888 | 2,718 |
Long-Term Investments | 0.64 | 56.25 | 1.71 | 1.7 | 0.7 |
Goodwill | 3,695 | 3,334 | 3,253 | 3,209 | 2,961 |
Other Intangible Assets | 469.22 | 523.08 | 582.86 | 608.78 | 663.06 |
Long-Term Deferred Tax Assets | 48.78 | 101.92 | 142.82 | 113.42 | 74.2 |
Other Long-Term Assets | 467.66 | 252.16 | 203.84 | 176.73 | 215.04 |
Total Assets | 18,388 | 16,213 | 15,355 | 14,218 | 12,676 |
Accounts Payable | 399.59 | 172.01 | 157.59 | 242.21 | 178.97 |
Accrued Expenses | - | 166.81 | 141.97 | 124.55 | 124.62 |
Short-Term Debt | - | 111.45 | 175.8 | 49.89 | 19.2 |
Current Portion of Long-Term Debt | 126.41 | 10.54 | 3.58 | 1.96 | 5.99 |
Current Portion of Leases | 77.12 | 62.34 | 65.54 | 59.37 | 57.28 |
Current Income Taxes Payable | 10.14 | 45.92 | 91.41 | 14.84 | 1.99 |
Other Current Liabilities | 453.96 | 398.48 | 427.68 | 282.84 | 216.17 |
Total Current Liabilities | 1,067 | 967.55 | 1,064 | 775.66 | 604.22 |
Long-Term Debt | 78.87 | 90.29 | 66.52 | 72.77 | 73.53 |
Long-Term Leases | 37.69 | 118.88 | 161.64 | 151 | 191.3 |
Pension & Post-Retirement Benefits | - | 12.15 | 7.15 | 4.13 | 7.58 |
Long-Term Deferred Tax Liabilities | 318.73 | 336.34 | 343.24 | 372.27 | 392.5 |
Other Long-Term Liabilities | 53.88 | 1.56 | 1.71 | 0.93 | 3.1 |
Total Liabilities | 1,556 | 1,527 | 1,644 | 1,377 | 1,272 |
Common Stock | 223.85 | 223.76 | 223.65 | 223.65 | 223.6 |
Additional Paid-In Capital | - | 840.22 | 821.31 | 821.31 | 813.55 |
Retained Earnings | - | 11,570 | 10,834 | 10,062 | 9,022 |
Comprehensive Income & Other | 16,096 | 1,575 | 1,363 | 1,244 | 826.43 |
Total Common Equity | 16,320 | 14,209 | 13,241 | 12,351 | 10,886 |
Minority Interest | 511.65 | 478.07 | 469.52 | 491.02 | 517.93 |
Shareholders' Equity | 16,831 | 14,687 | 13,711 | 12,842 | 11,404 |
Total Liabilities & Equity | 18,388 | 16,213 | 15,355 | 14,218 | 12,676 |
Total Debt | 320.09 | 393.5 | 473.08 | 334.99 | 347.3 |
Net Cash (Debt) | 6,678 | 5,529 | 4,988 | 4,488 | 3,362 |
Net Cash Growth | 20.77% | 10.85% | 11.14% | 33.49% | 15.63% |
Net Cash Per Share | 59.60 | 49.37 | 44.58 | 40.14 | 30.05 |
Filing Date Shares Outstanding | 111.88 | 111.88 | 111.82 | 111.82 | 111.8 |
Total Common Shares Outstanding | 111.88 | 111.88 | 111.82 | 111.82 | 111.8 |
Working Capital | 9,369 | 7,831 | 7,034 | 6,445 | 5,440 |
Book Value Per Share | 145.86 | 127.00 | 118.41 | 110.45 | 97.37 |
Tangible Book Value | 12,156 | 10,351 | 9,405 | 8,533 | 7,262 |
Tangible Book Value Per Share | 108.65 | 92.52 | 84.11 | 76.31 | 64.96 |
Land | - | 574.43 | 568.36 | 559.12 | 517.39 |
Buildings | - | 843.09 | 730.58 | 723.47 | 627.92 |
Machinery | - | 2,958 | 2,666 | 2,500 | 2,342 |
Construction In Progress | - | 216.91 | 307.37 | 156.09 | 96.28 |
Leasehold Improvements | - | 127.05 | 126.51 | 115.34 | 103.32 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.